NM_001024630.4:c.174_188delACAGCAGCAGCAGCA

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS1_SupportingBS2

The NM_001024630.4(RUNX2):​c.174_188delACAGCAGCAGCAGCA​(p.Gln59_Gln63del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000171 in 1,602,446 control chromosomes in the GnomAD database, including 1 homozygotes. It is difficult to determine the true allele frequency of this variant because it is of type DEL_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. Q58Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00019 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00017 ( 1 hom. )

Consequence

RUNX2
NM_001024630.4 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.14

Publications

0 publications found
Variant links:
Genes affected
RUNX2 (HGNC:10472): (RUNX family transcription factor 2) This gene is a member of the RUNX family of transcription factors and encodes a nuclear protein with an Runt DNA-binding domain. This protein is essential for osteoblastic differentiation and skeletal morphogenesis and acts as a scaffold for nucleic acids and regulatory factors involved in skeletal gene expression. The protein can bind DNA both as a monomer or, with more affinity, as a subunit of a heterodimeric complex. Two regions of potential trinucleotide repeat expansions are present in the N-terminal region of the encoded protein, and these and other mutations in this gene have been associated with the bone development disorder cleidocranial dysplasia (CCD). Transcript variants that encode different protein isoforms result from the use of alternate promoters as well as alternate splicing. [provided by RefSeq, Jul 2016]
RUNX2 Gene-Disease associations (from GenCC):
  • cleidocranial dysplasia 1
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000191 (29/151556) while in subpopulation SAS AF = 0.00167 (8/4786). AF 95% confidence interval is 0.000831. There are 0 homozygotes in GnomAd4. There are 11 alleles in the male GnomAd4 subpopulation. Median coverage is 30. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 29 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RUNX2NM_001024630.4 linkc.174_188delACAGCAGCAGCAGCA p.Gln59_Gln63del disruptive_inframe_deletion Exon 3 of 9 ENST00000647337.2 NP_001019801.3 Q13950-1
RUNX2NM_001369405.1 linkc.132_146delACAGCAGCAGCAGCA p.Gln45_Gln49del disruptive_inframe_deletion Exon 1 of 7 NP_001356334.1
RUNX2NM_001015051.4 linkc.174_188delACAGCAGCAGCAGCA p.Gln59_Gln63del disruptive_inframe_deletion Exon 3 of 8 NP_001015051.3 Q13950-3
RUNX2NM_001278478.2 linkc.132_146delACAGCAGCAGCAGCA p.Gln45_Gln49del disruptive_inframe_deletion Exon 1 of 6 NP_001265407.1 Q32MY8A0A0D9SEN7

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RUNX2ENST00000647337.2 linkc.174_188delACAGCAGCAGCAGCA p.Gln59_Gln63del disruptive_inframe_deletion Exon 3 of 9 NM_001024630.4 ENSP00000495497.1 Q13950-1

Frequencies

GnomAD3 genomes
AF:
0.000185
AC:
28
AN:
151444
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000391
Gnomad SAS
AF:
0.00146
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000177
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000194
AC:
46
AN:
236718
AF XY:
0.000238
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000307
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000117
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000102
Gnomad OTH exome
AF:
0.000175
GnomAD4 exome
AF:
0.000169
AC:
245
AN:
1450890
Hom.:
1
AF XY:
0.000204
AC XY:
147
AN XY:
721656
show subpopulations
African (AFR)
AF:
0.000213
AC:
7
AN:
32806
American (AMR)
AF:
0.0000461
AC:
2
AN:
43420
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25900
East Asian (EAS)
AF:
0.0000259
AC:
1
AN:
38612
South Asian (SAS)
AF:
0.00110
AC:
93
AN:
84854
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52124
Middle Eastern (MID)
AF:
0.000522
AC:
3
AN:
5742
European-Non Finnish (NFE)
AF:
0.000120
AC:
133
AN:
1107494
Other (OTH)
AF:
0.000100
AC:
6
AN:
59938
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.408
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000191
AC:
29
AN:
151556
Hom.:
0
Cov.:
30
AF XY:
0.000149
AC XY:
11
AN XY:
74064
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41414
American (AMR)
AF:
0.000131
AC:
2
AN:
15234
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3460
East Asian (EAS)
AF:
0.000392
AC:
2
AN:
5100
South Asian (SAS)
AF:
0.00167
AC:
8
AN:
4786
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10492
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.000177
AC:
12
AN:
67782
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
2
3
5
6
8
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000240
Hom.:
0
Asia WGS
AF:
0.000867
AC:
3
AN:
3476

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not provided Uncertain:1
Nov 04, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant, c.174_188del, results in the deletion of 5 amino acid(s) of the RUNX2 protein (p.Gln67_Gln71del), but otherwise preserves the integrity of the reading frame. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with RUNX2-related conditions. ClinVar contains an entry for this variant (Variation ID: 845536). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
3.1
Mutation Taster
=162/38
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs781355841; hg19: chr6-45390418; API